Home Healthcare Biotechnology Blood Products Market

Blood Products Market Size, Share & Trends Analysis Report By Product Type (Whole Blood, Red Blood Cells (RBCs), White Blood Cells, Platelets, Plasma, Others), By Application (Anemia, Hemophilia, Surgical Procedures, Trauma and Accident Care, Cancer Treatment, Immunodeficiency Diseases, Others), By End User (Hospitals, Blood Banks, Diagnostic Laboratories, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Blood Products Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Whole Blood
    2. Red Blood Cells (RBCs)
    3. White Blood Cells
    4. Platelets
    5. Plasma
      1. Fresh Frozen Plasma (FFP)
      2. Immunoglobulins
      3. Albumin
      4. Coagulation Factors
    6. Others
  2. Blood Products Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Anemia
    2. Hemophilia
    3. Surgical Procedures
    4. Trauma and Accident Care
    5. Cancer Treatment
    6. Immunodeficiency Diseases
    7. Others
  3. Blood Products Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Blood Banks
    3. Diagnostic Laboratories
    4. Ambulatory Surgical Centers
    5. Others 
  4. Regional Blood Products Market
    1. North America
      1. North America Blood Products Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
      2. North America Blood Products Market By Application 2022-2034 (USD MILLION/ Units)
        1. Anemia
        2. Hemophilia
        3. Surgical Procedures
        4. Trauma and Accident Care
        5. Cancer Treatment
        6. Immunodeficiency Diseases
        7. Others
      3. North America Blood Products Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Blood Banks
        3. Diagnostic Laboratories
        4. Ambulatory Surgical Centers
        5. Others 
      4. U.S.
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      5. Canada
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
    2. Europe
      1. Europe Blood Products Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
      2. Europe Blood Products Market By Application 2022-2034 (USD MILLION/ Units)
        1. Anemia
        2. Hemophilia
        3. Surgical Procedures
        4. Trauma and Accident Care
        5. Cancer Treatment
        6. Immunodeficiency Diseases
        7. Others
      3. Europe Blood Products Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Blood Banks
        3. Diagnostic Laboratories
        4. Ambulatory Surgical Centers
        5. Others 
      4. U.K.
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      5. Germany
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      6. France
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      7. Spain
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      8. Italy
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      9. Russia
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      10. Nordic
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      11. Benelux
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      12. Rest of Europe
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
    3. APAC
      1. APAC Blood Products Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
      2. APAC Blood Products Market By Application 2022-2034 (USD MILLION/ Units)
        1. Anemia
        2. Hemophilia
        3. Surgical Procedures
        4. Trauma and Accident Care
        5. Cancer Treatment
        6. Immunodeficiency Diseases
        7. Others
      3. APAC Blood Products Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Blood Banks
        3. Diagnostic Laboratories
        4. Ambulatory Surgical Centers
        5. Others 
      4. China
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      5. Korea
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      6. Japan
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      7. India
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      8. Australia
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      9. Taiwan
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      10. South East Asia
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      11. Rest of Asia-Pacific
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
    4. Middle East and Africa
      1. Middle East and Africa Blood Products Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
      2. Middle East and Africa Blood Products Market By Application 2022-2034 (USD MILLION/ Units)
        1. Anemia
        2. Hemophilia
        3. Surgical Procedures
        4. Trauma and Accident Care
        5. Cancer Treatment
        6. Immunodeficiency Diseases
        7. Others
      3. Middle East and Africa Blood Products Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Blood Banks
        3. Diagnostic Laboratories
        4. Ambulatory Surgical Centers
        5. Others 
      4. UAE
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      5. Turkey
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      6. Saudi Arabia
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      7. South Africa
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      8. Egypt
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      9. Nigeria
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      10. Rest of MEA
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
    5. LATAM
      1. LATAM Blood Products Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
      2. LATAM Blood Products Market By Application 2022-2034 (USD MILLION/ Units)
        1. Anemia
        2. Hemophilia
        3. Surgical Procedures
        4. Trauma and Accident Care
        5. Cancer Treatment
        6. Immunodeficiency Diseases
        7. Others
      3. LATAM Blood Products Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Blood Banks
        3. Diagnostic Laboratories
        4. Ambulatory Surgical Centers
        5. Others 
      4. Brazil
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      5. Mexico
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      6. Argentina
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      7. Chile
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      8. Colombia
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
      9. Rest of LATAM
        1. Whole Blood
        2. Red Blood Cells (RBCs)
        3. White Blood Cells
        4. Platelets
        5. Plasma
          1. Fresh Frozen Plasma (FFP)
          2. Immunoglobulins
          3. Albumin
          4. Coagulation Factors
        6. Others
        7. Anemia
        8. Hemophilia
        9. Surgical Procedures
        10. Trauma and Accident Care
        11. Cancer Treatment
        12. Immunodeficiency Diseases
        13. Others
        14. Hospitals
        15. Blood Banks
        16. Diagnostic Laboratories
        17. Ambulatory Surgical Centers
        18. Others 
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.